Latest News

Fast-food chain McDonald’s (NYSE:MCD) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.5% year on year to $5.96 billion. Its non-GAAP profit of $2.67 per share was in line with analysts’ consensus estimates.

Building products company Boise Cascade Company (NYSE:BCC) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 6.6% year on year to $1.54 billion. Its GAAP profit of $1.06 per share was 19.7% below analysts’ consensus estimates.

Slot machine and terminal operator Accel Entertainment (NYSE:ACEL) announced better-than-expected revenue in Q1 CY2025, with sales up 7.3% year on year to $323.9 million. Its GAAP profit of $0.17 per share was 43.6% above analysts’ consensus estimates.

Infrastructure construction company Primoris (NYSE:PRIM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 16.7% year on year to $1.65 billion. Its non-GAAP profit of $0.98 per share was 49.4% above analysts’ consensus estimates.

Automotive manufacturer Ford (NYSE:F) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 5% year on year to $40.66 billion. Its non-GAAP profit of $0.14 per share was significantly above analysts’ consensus estimates.

Water infrastructure products manufacturer Mueller Water Products beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 3.1% year on year to $364.3 million. The company’s full-year revenue guidance of $1.40 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $0.34 per share was 9.7% above analysts’ consensus estimates.

Fragrance and perfume company Inter Parfums (NASDAQ:IPAR) announced better-than-expected revenue in Q1 CY2025, with sales up 4.6% year on year to $338.8 million. The company expects the full year’s revenue to be around $1.51 billion, close to analysts’ estimates. Its GAAP profit of $1.32 per share was 17.3% above analysts’ consensus estimates.

Nutrition products company Bellring Brands (NYSE:BRBR) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 18.9% year on year to $588 million. On the other hand, the company’s full-year revenue guidance of $2.3 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.53 per share was in line with analysts’ consensus estimates.

Hospitality company Playa Hotels & Resorts (NASDAQ:PLYA) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 11.1% year on year to $267.3 million. Its non-GAAP profit of $0.37 per share was 12% above analysts’ consensus estimates.

Aerospace and defense company BWX (NYSE:BWXT) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 13% year on year to $682.3 million. On the other hand, the company’s full-year revenue guidance of $3 billion at the midpoint came in 0.9% below analysts’ estimates. Its non-GAAP profit of $0.91 per share was 19% above analysts’ consensus estimates.

Maritime transportation company Matson (NYSE:MATX) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 8.3% year on year to $782 million. Its GAAP profit of $2.18 per share was 3.8% below analysts’ consensus estimates.

Medical device company Artivion (NYSE:AORT) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 1.6% year on year to $98.98 million. The company’s full-year revenue guidance of $429 million at the midpoint came in 1.2% above analysts’ estimates. Its non-GAAP profit of $0.06 per share was $0.02 above analysts’ consensus estimates.

Toy manufacturing and entertainment company (NASDAQ:MAT) announced better-than-expected revenue in Q1 CY2025, with sales up 2.1% year on year to $826.6 million. Its non-GAAP loss of $0.03 per share was 70.4% above analysts’ consensus estimates.

Biopharma company Corcept Therapeutics (NASDAQ:CORT) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 7.1% year on year to $157.2 million. On the other hand, the company’s full-year revenue guidance of $925 million at the midpoint came in 2.2% above analysts’ estimates. Its GAAP profit of $0.17 per share was 20.8% above analysts’ consensus estimates.

Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 111% year on year to $586 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $540 million was less impressive, coming in 4.3% below expectations. Its GAAP profit of $0.20 per share was 66.4% above analysts’ consensus estimates.

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 20.3% year on year to $337.7 million. Its non-GAAP profit of $1.42 per share was 6.5% above analysts’ consensus estimates.